Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-173491

Xenbase Image ID: 173491


Fig. S5. (related to Fig. 4) Depleting the zygotic Ascl1a using a splice blocking MO (spMO) (A). A schematic presentation of ascl1a gene containing a single intron of 615 bp long in the 3’UTR. The Ascl1a splice blocking MO (spMO) recognizes the donor sites. The unspliced mRNA is predicted to yield a PCR product of 1100 bp long. (B). PCR verification of the primers designed for assessing the effects of Ascl1a spMO using genomic DNA template or cDNA templates made from oocytes and embryos at different developmental stages. (C). RT-PCR results showing that injection Ascl1a spMO markedly increased the unspliced mRNA in stage 16 embryos and therefore the PCR products of 1100bp long. (D). cMO and Ascl1a spMO injected embryos at different stages of development. (E). qPCR detection of tubb2b expression in Ascl1a morphants at stage 18. Values are mean ± s.d. *P<0.05.

Image published in: Gao L et al. (2016)

© 2016. This image is reproduced with permission of the journal and the copyright holder. This is an open-access article distributed under the terms of the Creative Commons Attribution license

Larger Image
Printer Friendly View

Return to previous page